MitoQ in sepsis-associated acute lung injury: redox pharmacology, mechanistic evidence, and translational perspectives
Current evidence supports MitoQ primarily as an upstream mitochondrial redox modulator with potential to preserve alveolar–capillary function, and future studies should prioritise post-onset treatment, pulmonary and mitochondrial target engagement, pathway-specific causal validation, and assessment of host defence to d...